RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 201–300 of 1,027
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes
STERN, D., YAN, S., YAN, S., & SCHMIDT, A. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00366-9 · Cited by 266
Self-citationButterfield, D. A., & Boyd-Kimball, D. (2005) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267
“[84].”
Yamada, Y., Doi, T., Hamakubo, T., & Kodama, T. (1998) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s000180050191 · Cited by 268
Kook, S.-Y., Hong, H. S., Moon, M., Ha, C. M., Chang, S., & Mook-Jung, I. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.6102-11.2012 · Cited by 265
“These results are consistent with previous reports of increased RAGE expression in the vascular system in AD brain (Yan et al., 1996).”
BackgroundResultHoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265
“RAGE are present in the nervous tissue (Brett et al., 1993), and both the amyloidogenic APP derivative -A4 and AGE bind to RAGE (Yan et al., 1996).”
BackgroundInfluentialDiabetes mellitus in midlife and the risk of dementia three decades later
Schnaider Beeri, M., Goldbourt, U., Silverman, J. M., Noy, S., Schmeidler, J., Ravona-Springer, R., Sverdlick, A., & Davidson, M. (2004) · Neurology · doi:10.1212/01.wnl.0000144278.79488.dd · Cited by 262
Leclerc, E., Fritz, G., Weibel, M., Heizmann, C. W., & Galichet, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703951200 · Cited by 262
Verdier, Y., Zarándi, M., & Penke, B. (2004) · Journal of Peptide Science · doi:10.1002/psc.573 · Cited by 262
Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., & Winkler, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07002.x · Cited by 261
Abuznait, A. H., Qosa, H., Busnena, B. A., El Sayed, K. A., & Kaddoumi, A. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400024q · Cited by 259
Tissue-specific Role of CX3CR1 Expressing Immune Cells and Their Relationships with Human Disease
Lee, M., Lee, Y., Song, J., Lee, J., & Chang, S.-Y. (2018) · Immune Network · doi:10.4110/in.2018.18.e5 · Cited by 260
Olcese, J. M., Cao, C., Mori, T., Mamcarz, M. B., Maxwell, A., Runfeldt, M. J., Wang, L., Zhang, C., Lin, X., Zhang, G., et al. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00692.x · Cited by 260
“Considerable data indicate that oxidative stress contributes to the neuropathology of AD [56, 57].”
BackgroundLorenzo, A., Yuan, M., Zhang, Z., Paganetti, P. A., Sturchler-Pierrat, C., Staufenbiel, M., Mautino, J., Vigo, F. S., Sommer, B., & Yankner, B. A. (2000) · Nature Neuroscience · doi:10.1038/74833 · Cited by 258
“One example is the receptor for advanced glycation end products (RAGE), which is implicated in Aβ neurotoxicit”
BackgroundPaudel, Y. N., Angelopoulou, E., Piperi, C., Othman, I., Aamir, K., & Shaikh, M. F. (2020) · Cells · doi:10.3390/cells9020383 · Cited by 257
RAGE and TLRs: Relatives, friends or neighbours?
Ibrahim, Z. A., Armour, C. L., Phipps, S., & Sukkar, M. B. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.008 · Cited by 257
Alzheimer's disease: a re-examination of the amyloid hypothesis
Neve, R. L., & Robakis, N. K. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01168-5 · Cited by 256
Apolipoprotein J (clusterin) and Alzheimer's disease
Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., & Ghiso, J. (2000) · Microscopy Research and Technique · doi:10.1002/1097-0029(20000815)50:4<305::aid-jemt10>3.0.co;2-l · Cited by 256
Structural Analysis of Alzheimer's β(1–40) Amyloid: Protofilament Assembly of Tubular Fibrils
Malinchik, S. B., Inouye, H., Szumowski, K. E., & Kirschner, D. A. (1998) · Biophysical Journal · doi:10.1016/s0006-3495(98)77812-9 · Cited by 255
“Both Ab(1–40) and Ab(25–35), which contain the sequence of Ab(22–35), are neurotoxic in fiber form (Yan et al., 1996; El-Khoury et al., 1996), suggesting that the twisted form of the fiber or ribbon structure may harbor a molecular structure with a high affinity for the putative receptor.”
BackgroundThe cause of neuronal degeneration in Alzheimer’s disease
Vickers, J. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00023-4 · Cited by 254
Sasaki, N., Toki, S., Chowei, H., Saito, T., Nakano, N., Hayashi, Y., Takeuchi, M., & Makita, Z. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03075-4 · Cited by 253
Structural Basis for Pattern Recognition by the Receptor for Advanced Glycation End Products (RAGE)
Xie, J., Reverdatto, S., Frolov, A., Hoffmann, R., Burz, D. S., & Shekhtman, A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801622200 · Cited by 252
McDonald, D. R., Bamberger, M. E., Combs, C. K., & Landreth, G. E. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-12-04451.1998 · Cited by 252
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
“RAGE mediates Ab-induced neurotoxicity directly by causing oxidant stress and indirectly by activating microglia (Yan et al. 1996).”
BackgroundInfluentialRegulation of monocyte migration by amphoterin (HMGB1)
Rouhiainen, A. (2004) · Blood · doi:10.1182/blood-2003-10-3536 · Cited by 250
Demling, N., Ehrhardt, C., Kasper, M., Laue, M., Knels, L., & Rieber, E. P. (2006) · Cell and Tissue Research · doi:10.1007/s00441-005-0069-0 · Cited by 249
“This also holds true even for brain tissue in which RAGE has been described as being involved in neurite outgrowth and in complications occurring in Alzheimer’s disease (Hori et al. 1995; Yan et al. 1996).”
BackgroundBiomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment
Mangialasche, F., Polidori, M. C., Monastero, R., Ercolani, S., Camarda, C., Cecchetti, R., & Mecocci, P. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2009.04.002 · Cited by 248
“Furthermore, AGEs and A b activate specific receptors, such as that for advanced glycation end products (RAGE) and the class A scavenger-receptor, which increase ROS production (El Khoury et al., 1996; Yan et al., 1996).”
Hensley, K. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1414 · Cited by 248
“Aβ has been well-documented to promote microglial activation through action on scavenger receptors, chemokine receptors, receptors for advanced glycation end products (RAGE) and possibly by other means [64–66].”
Microglial Aβ Receptors in Alzheimer’s Disease
Yu, Y., & Ye, R. D. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-014-0101-6 · Cited by 247
Adult neuron survival strategies — slamming on the brakes
Benn, S. C., & Woolf, C. J. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1477 · Cited by 245
“fcgi?db=gene&cmd=Retrieve&dopt=Graphics&list_uids=94275">NRAGE )-mediated deat”
ISHIZUKA, K., KIMURA, T., IGATA‐YI, R., KATSURAGI, S., TAKAMATSU, J., & MIYAKAWA, T. (1997) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1997.tb02375.x · Cited by 245
Bates, K. A., Verdile, G., Li, Q.-X., Ames, D., Hudson, P., Masters, C. L., & Martins, R. N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.96 · Cited by 247
Mitotic signaling by β‐amyloid causes neuronal death
COPANI, A., CONDORELLI, F., CARUSO, A., VANCHERI, C., SALA, A., STELLA, A. M. G., CANONICO, P. L., NICOLETTI, F., & SORTINO, M. A. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.15.2225 · Cited by 245
Park, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Loeser, R. F., Yammani, R. R., Carlson, C. S., Chen, H., Cole, A., Im, H., Bursch, L. S., & Yan, S. D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21199 · Cited by 243
“Primary chondrocytes were transfected with a plasmid expressing full-length RAGE complementary DNA (cDNA) (21) using the Nucleofection method (Human Chondrocyte Nucleofector kit; Amaxa, Gaithersburg, MD).”
BackgroundMethodSelf-citationExtracellular protein components of amyloid plaques and their roles in Alzheimer’s disease pathology
Rahman, M. M., & Lendel, C. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00465-0 · Cited by 239
Szczepanik, A. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00404-5 · Cited by 243
Pappolla, M. A., Chyan, Y. J., Poeggeler, B., Frangione, B., Wilson, G., Ghiso, J., & Reiter, R. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050018 · Cited by 243
“Induction of free radicals may be initiated by binding of Aâ to cell surface receptors such as the advanced glycated end products (AGE) (Yan et al., 1996), although involvement of other Aâ-binding proteins (Yan et al., 1999) or receptor independent mechanisms may also be implicated (Pappolla et…”
BackgroundRapid astrocyte and microglial activation following pilocarpine-induced seizures in rats
Shapiro, L. A., Wang, L., & Ribak, C. E. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01491.x · Cited by 242
“Moreover, S100B stimulates microglial cell activation (Yan et al., 1996; Sheng et al., 1997) and S100B expression is increased 30 days after kainate-induced lesions (Bendotti et al., 2000).”
BackgroundMackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
“The list of specific receptor- and/or carriermediated BBB mechanism(s) participating in cerebrovascular accumulation, deposition, and brain transfer of blood-borne Ab1–40, the Dutch mutant vasculotropic peptide (AbQ) (22) and Ab1–42 free or complexed with apoJ and apoE4 (21, 32, 38), and/or mediating vascular endothel…”
BackgroundMethodInfluentialSelf-citationPrion protein and Aβ‐related synaptic toxicity impairment
Calella, A. M., Farinelli, M., Nuvolone, M., Mirante, O., Moos, R., Falsig, J., Mansuy, I. M., & Aguzzi, A. (2010) · EMBO Molecular Medicine · doi:10.1002/emmm.201000082 · Cited by 242
“Several membrane proteins have been reported to bind soluble Ab oligomers—thereby candidat- ing as potential transducers of toxicity (Deane et al, 2004; De Felice et al, 2009; Shankar et al, 2007; Snyder et al, 2005; Yan et al, 1996).”
Receptor for Advanced Glycation End Products and Its Involvement in Inflammatory Diseases
Chuah, Y. K., Basir, R., Talib, H., Tie, T. H., & Nordin, N. (2013) · International Journal of Inflammation · doi:10.1155/2013/403460 · Cited by 240
Wendt, T., Tanji, N., Guo, J., Hudson, B. I., Bierhaus, A., Ramasamy, R., Arnold, B., Nawroth, P. P., Yan, S. F., D’Agati, V., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000065100.17349.ca · Cited by 239
Self-citationProtein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic Compounds
Stefani, M., & Rigacci, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140612411 · Cited by 238
“Since 1996, the receptor for advanced glycation end products (RAGE) has been proposed as a major candidate as amyloid receptor [110–112].”
BackgroundYan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0439-2 · Cited by 237
“Signal transduction is essential for the biological actions of RAGE, as RAGE ligand-dependent actions are blocked upon deletion of the cytoplasmic domain of RAGE [3, 5, 6, 10].”
BackgroundSelf-citationProtein oxidation in aging and the removal of oxidized proteins
Höhn, A., König, J., & Grune, T. (2013) · Journal of Proteomics · doi:10.1016/j.jprot.2013.01.004 · Cited by 238
“RAGE is predominantly expressed in monocytes/macrophages, mesangial cells, vascular smooth muscle cells, endothelial cells and neuronal cells [188,189].”
BackgroundGanesh, S. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.11.1251 · Cited by 236
Use of curcumin in diagnosis, prevention, and treatment of Alzheimer's disease
Zhang, K., Chen, M., Du, Z.-Y., Zheng, X., Li, D.-L., & Zhou, R.-P. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.230303 · Cited by 234
“In turn, this induces inflammatory responses and increases Aβ influx, giving rise to further brain damage and ensuing cognitive impairment (Yan et al., 1996).”
BackgroundSelf-citationEscribano, L., Simón, A.-M., Gimeno, E., Cuadrado-Tejedor, M., López de Maturana, R., García-Osta, A., Ricobaraza, A., Pérez-Mediavilla, A., Del Río, J., & Frechilla, D. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.32 · Cited by 235
Importance of MAPK pathways for microglial pro-inflammatory cytokine IL-1β production
Kim, S. H., Smith, C. J., & Van Eldik, L. J. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00126-x · Cited by 235
“A has been reported to bind to a number of different receptors on microglia, including RAGE, scavenger receptors, and a multi-subunit complex of proteins [4,15,73].”
BackgroundCha, M.-Y., Han, S.-H., Son, S. M., Hong, H.-S., Choi, Y.-J., Byun, J., & Mook-Jung, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034929 · Cited by 231
“The receptor for advanced glycation endproduct (RAGE) is the binding receptor for Ab, and RAGEAb engagement has been reported to modulate diverse signaling pathways, such as NF-kB, p38 mitogen-activated protein kinase and ERK1/2 activation [24,25,26,27].”
BackgroundThe roles of TNF in brain dysfunction and disease
Clark, I. A., Alleva, L. M., & Vissel, B. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.08.007 · Cited by 232
“RAGEbearing cells include neurons and microglia (Yan et al., 1996).”
Cardiovascular risk factors and dementia
Fillit, H., Nash, D. T., Rundek, T., & Zuckerman, A. (2008) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2008.06.004 · Cited by 225
Insulin Resistance in Alzheimer's Disease
Ferreira, L. S. S., Fernandes, C. S., Vieira, M. N. N., & De Felice, F. G. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00830 · Cited by 228
“Importantly, AGE-receptor (RAGE) was suggested as a possible receptor for Aβ (Yan et al., 1996) and to mediate Abeta toxic mechanisms such as induction of ER-stress (Chen et al., 2018).”
BackgroundDemonstrating the case that AD is a vascular disease: epidemiologic evidence
LAUNER, L. (2002) · Ageing Research Reviews · doi:10.1016/s0047-6374(01)00364-5 · Cited by 227
RAGE in tissue homeostasis, repair and regeneration
Sorci, G., Riuzzi, F., Giambanco, I., & Donato, R. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.10.021 · Cited by 227
Amyloid β-Protein Toxicity and the Pathogenesis of Alzheimer Disease
Yankner, B. A., & Lu, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800018200 · Cited by 227
Oczypok, E. A., Perkins, T. N., & Oury, T. D. (2017) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2017.03.012 · Cited by 226
Reactive oxygen species and Alzheimer's disease
Multhaup, G., Ruppert, T., Schlicksupp, A., Hesse, L., Beher, D., Masters, C. L., & Beyreuther, K. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00062-2 · Cited by 227
Advanced glycation end‐products and the kidney
Busch, M., Franke, S., Rüster, C., & Wolf, G. (2010) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2010.02317.x · Cited by 226
Serrano-Pozo, A., Muzikansky, A., Gómez-Isla, T., Growdon, J. H., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182933788 · Cited by 226
Peiser, L., & Gordon, S. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01362-9 · Cited by 225
The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target
O’Brien, W. T., Pham, L., Symons, G. F., Monif, M., Shultz, S. R., & McDonald, S. J. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01778-5 · Cited by 222
Yang, R., Harada, T., Mollen, K. P., Prince, J. M., Levy, R. M., Englert, J. A., Gallowitsch-Puerta, M., Yang, L., Yang, H., Tracey, K. J., et al. (2006) · Molecular Medicine · doi:10.2119/2006-00010.yang · Cited by 224
Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond
Daffu, G., Del Pozo, C., O'Shea, K., Ananthakrishnan, R., Ramasamy, R., & Schmidt, A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141019891 · Cited by 222
“In addition to AGEs, RAGE transduces the signals of distinct ligands, such as multiple members of the S100/calgranulin family [4], high mobility group box 1 (HMGB1) [5], amyloid beta-peptide and beta-sheet fibrils [6], lysophosphatidic acid (LPA) [7], Mac1 [8], and C1q [9].”
BackgroundSelf-citationManda, K., Ueno, M., & Anzai, K. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00432.x · Cited by 222
Smith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N., & Perry, G. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222
Glial activation in Alzheimer's disease: the role of Aβ and its associated proteins
Meda, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00307-4 · Cited by 222
Microglia in diseases of the central nervous system
Nelson, P. T., Soma, L. A., & Lavi, E. (2002) · Annals of Medicine · doi:10.1080/078538902321117698 · Cited by 222
Toxicity of Amyloid β Peptide: Tales of Calcium, Mitochondria, and Oxidative Stress
Canevari, L., Abramov, A. Y., & Duchen, M. R. (2004) · Neurochemical Research · doi:10.1023/b:nere.0000014834.06405.af · Cited by 222
“RAGE have also been shown to activate the NADPH oxidase (107), and their expression is enhanced during AD in neurons, microglia, and astrocytes (108).”
BackgroundOxidant/Antioxidant Imbalance in Alzheimer’s Disease: Therapeutic and Diagnostic Prospects
Wojsiat, J., Zoltowska, K. M., Laskowska-Kaszub, K., & Wojda, U. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6435861 · Cited by 221
“RAGE is the receptor for AGE, and it is a pattern recognition receptor that binds multiple ligands derived from damaged cell environment [76] as well as Aβ [77].”
BackgroundAssociation of Duration and Severity of Diabetes Mellitus With Mild Cognitive Impairment
Roberts, R. O., Geda, Y. E., Knopman, D. S., Christianson, T. J. H., Pankratz, V. S., Boeve, B. F., Vella, A., Rocca, W. A., & Petersen, R. C. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1066 · Cited by 221
“It has been hypothesized that defects in insulin action may increase amyloid- aggregation.(11,12,35) In type 2 DM, insulin therapy may inhibit synaptic activity in the brain,(36) decrease insulin-degrading enzyme production, promote the development of amyloid plaques,(11,12) and increase production of advanced glycati…”
Ying, G., Iribarren, P., Zhou, Y., Gong, W., Zhang, N., Yu, Z.-X., Le, Y., Cui, Y., & Wang, J. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.7078 · Cited by 219
Giri, R., Shen, Y., Stins, M., Du Yan, S., Schmidt, A. M., Stern, D., Kim, K.-S., Zlokovic, B., & Kalra, V. K. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.6.c1772 · Cited by 218
Self-citationRushworth, J. V., & Hooper, N. M. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/603052 · Cited by 215
“The α7 nicotinic acetylcholine receptor (nAChRα7) and the receptor for advanced glycation end products (RAGE) were also assayed due to their previously reported affinities for Aβ peptides [103, 104], although neither displayed high-affinity Aβ oligomer binding.”
BackgroundA Role for the Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis
Englert, J. M., Hanford, L. E., Kaminski, N., Tobolewski, J. M., Tan, R. J., Fattman, C. L., Ramsgaard, L., Richards, T. J., Loutaev, I., Nawroth, P. P., et al. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070569 · Cited by 218
Self-citationZhong, L., Wang, Z., Wang, D., Wang, Z., Martens, Y. A., Wu, L., Xu, Y., Wang, K., Li, J., Huang, R., et al. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0247-7 · Cited by 217
Self-citationHanford, L. E., Enghild, J. J., Valnickova, Z., Petersen, S. V., Schaefer, L. M., Schaefer, T. M., Reinhart, T. A., & Oury, T. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409782200 · Cited by 217
Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease
Farfara, D., Lifshitz, V., & Frenkel, D. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00314.x · Cited by 216
Frenkel, D., Wilkinson, K., Zhao, L., Hickman, S. E., Means, T. K., Puckett, L., Farfara, D., Kingery, N. D., Weiner, H. L., & El Khoury, J. (2013) · Nature Communications · doi:10.1038/ncomms3030 · Cited by 214
Self-citationChen, K., Iribarren, P., Hu, J., Chen, J., Gong, W., Cho, E. H., Lockett, S., Dunlop, N. M., & Wang, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508125200 · Cited by 214
Narayanaswami, V., Dahl, K., Bernard-Gauthier, V., Josephson, L., Cumming, P., & Vasdev, N. (2018) · Molecular Imaging · doi:10.1177/1536012118792317 · Cited by 213
Sousa, M. M., Du Yan, S., Fernandes, R., Guimarães, A., Stern, D., & Saraiva, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07576.2001 · Cited by 212
“In each case, the receptor recruits signal transduction mechanisms, often resulting in a sustained and pathogenic inflammatory response (Yan et al., 1996; Schmidt et al., 1999; Hofmann et al., 2001).”
BackgroundMethodSelf-citationInflammation in the early stages of neurodegenerative pathology
Khandelwal, P. J., Herman, A. M., & Moussa, C. E.-H. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.07.002 · Cited by 212
“Aβ peptides as well as Aβ oligomers bind to RAGE and microglia (Yan et al., 1996).”
BackgroundMitochondrial dysfunction in microglia: a novel perspective for pathogenesis of Alzheimer’s disease
Li, Y., Xia, X., Wang, Y., & Zheng, J. C. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02613-9 · Cited by 207
Chung, H., Brazil, M. I., Soe, T. T., & Maxfield, F. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.45.32301 · Cited by 212
Cohen, R. A., Plane, F., Najibi, S., Huk, I., Malinski, T., & Garland, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4193 · Cited by 212
Role of p38/MAPKs in Alzheimer's Disease: Implications for Amyloid Beta Toxicity Targeted Therapy
Kheiri, G., Dolatshahi, M., Rahmani, F., & Rezaei, N. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0008 · Cited by 211
Ishiguro, H., Nakaigawa, N., Miyoshi, Y., Fujinami, K., Kubota, Y., & Uemura, H. (2005) · The Prostate · doi:10.1002/pros.20219 · Cited by 211
Egaña-Gorroño, L., López-Díez, R., Yepuri, G., Ramirez, L. S., Reverdatto, S., Gugger, P. F., Shekhtman, A., Ramasamy, R., & Schmidt, A. M. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00037 · Cited by 211
Self-citationAmyloid-β causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons
Chiba, T., Yamada, M., Sasabe, J., Terashita, K., Shimoda, M., Matsuoka, M., & Aiso, S. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.105 · Cited by 194
“To the best of our knowledge, none of the known targets of Aβ, such as the receptor for advanced glycation end products”
BackgroundAstrocytic clasmatodendrosis in hippocampal organ culture
Hulse, R. E., Winterfield, J., Kunkler, P. E., & Kraig, R. P. (2001) · Glia · doi:10.1002/1098-1136(200102)33:2<169::aid-glia1016>3.0.co;2-b · Cited by 85
Park, S.-Y., Kim, H.-S., Cho, E.-K., Kwon, B.-Y., Phark, S., Hwang, K.-W., & Sul, D. (2008) · Food and Chemical Toxicology · doi:10.1016/j.fct.2008.05.030 · Cited by 209
Stitt, A. W. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-5881 · Cited by 206
Ding, B., Lin, C., Liu, Q., He, Y., Ruganzu, J. B., Jin, H., Peng, X., Ji, S., Ma, Y., & Yang, W. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01981-4 · Cited by 207
Septic Shock Is Associated with Receptor for Advanced Glycation End Products Ligation of LPS
Yamamoto, Y., Harashima, A., Saito, H., Tsuneyama, K., Munesue, S., Motoyoshi, S., Han, D., Watanabe, T., Asano, M., Takasawa, S., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002253 · Cited by 207
Li, Y., Zhang, J., Wan, J., Liu, A., & Sun, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110887 · Cited by 197
Chakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T. E., & Das, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903382 · Cited by 206
AGEs induce Alzheimer-like tau pathology and memory deficit via RAGE-mediated GSK-3 activation
Li, X.-H., Lv, B.-L., Xie, J.-Z., Liu, J., Zhou, X.-W., & Wang, J.-Z. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.003 · Cited by 205
“…(Guglielmotto et al., 2010). ecent studies have demonstrated that RAGE plays an imortant role in A -mediated neurotoxicities (Takuma et al., 2009; Yan et al., 1996), and RAGE-dependent signaling contributes to an impaired learning/memory in AD-like transgenic models (Arancio et al., 2004; Fang…”
Aβ-Induced Inflammatory Processes in Microglia Cells of APP23 Transgenic Mice
Bornemann, K. D., Wiederhold, K.-H., Pauli, C., Ermini, F., Stalder, M., Schnell, L., Sommer, B., Jucker, M., & Staufenbiel, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63945-4 · Cited by 206
“Candidate receptors are SRA and RAGE, which were shown in vitro to mediate adhesion to Ab fibrils and activation of microglia cells.(10,11,26) An up-regulation of SRA, at sites where microglial processes interact with Ab, indicates that this receptor may be responsible for activation and accumulation of microglia at t…”
BackgroundRamanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205
“Interestingly, RAGE expression levels are increased in AD endothelium that is associated with cerebrovascular and brain accumulation of Aβ (Yan et al., 1996; Deane et al., 2003, 2012; Silverberg et al., 2010).”
Background
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.